ATHA Investor Reminder: Kessler Topaz Meltzer & Check, LLP at Athira Pharma, Inc.Announcement of deadlines for class action proceedings in securities fraud filed against | Around the Web-Pennsylvania –


Radnor, Pennsylvania, July 12, 2021 / PRNewswire / -Kessler Topaz Meltzer & Check, LLP law firm tells investors, securities fraud class action athira Pharma, Inc. (NASDAQ: ATHA) (“Athira”), buyer or acquired Athira common stock: a) Compliant and / or traceable for registration notifications and prospectuses (collectively, “registration notifications”) issued in connection with Athira September 2020 Initial public offering; and / or b) September 18, 2020 And June 17, 2021, Comprehensive (“class period”).

Plaintiff’s main deadline: August 24, 2021


contact information: James Maro, Esq. (484) 270-1453

Adrian Bell, Esq. (484) 270-1435

Toll free number (844) 887-9500

Athira is a late-stage clinical biopharmacy company focused on developing small molecules to restore neuronal health and stop neurodegeneration.

The complaint alleges that throughout the registration statement and / or the duration of the lesson, the defendant made a substantially false and misleading statement, omitting the following statement: (1) Dr. Athira, President and Chief Executive Officer Lean Kawas, Published a research treatise containing images that were improperly modified when she was a graduate student. (2) This study laid the biological basis that Athira used in her approach to the treatment of Alzheimer’s disease, and thus laid the foundation for Atila’s efforts to develop treatments for Alzheimer’s disease. (3) As a result, Atila’s intellectual property and product development for the treatment of Alzheimer’s disease was based on invalid research. (4) As a result of the above, Defendant’s affirmative statement regarding Atila’s business, operations and outlook was substantially misleading and / or lacked reasonable grounds.

Athira investors At the latest August 24, 2021We request that you be appointed as the Class’s Chief Plaintiff Representative through, Kessler Topaz Meltzer & Check, LLP, or any other attorney. Alternatively, you can leave the class members absent without doing anything. The plaintiff chief is the representative party acting on behalf of all class members in conducting the proceedings. To be appointed as Chief Plaintiff, the court must determine that the claims of a class member are typical of the claims of other class members and that the class members properly represent the class. The ability to share recovery is unaffected by the decision to act as the main plaintiff.

Kessler Topaz Meltzer & Check, LLP, will prosecute class actions in state and federal courts nationwide, including securities fraud, fiduciary duty breaches, and other state and federal law breaches. Kessler Topaz Meltzer & Check, LLP, is the driving force behind corporate governance reform and has recovered billions of dollars on behalf of institutional and individual investors. United States of America And all over the world. The company represents investors, consumers and whistleblowers (private sector who report fraud against the government and share the government’s dollar recovery). The complaints in this proceeding were not filed by Kessler Topaz Meltzer & Check, LLP. For more information on Kessler Topaz Meltzer & Check, LLP, please visit:

contact information:

Kessler Topaz Meltzer & Check, LLP

James Maro, Jr., Esq.

Adrian Bell, Esq.

280 King of Prussia Road

Radnor, Pennsylvania 19087

(844) 887-9500 (toll free)

To download multimedia, view the original content.–kessler-topaz-meltzer–check-llp-announces-deadline-in-securities-fraud-class-action-lawsuit-filed- Against -athira-pharma-inc-301328612.html

Source Kessler Topaz Meltzer & Check, LLP


Please enter your comment!
Please enter your name here